PMID- 29732483
OWN - NLM
STAT- MEDLINE
DCOM- 20181105
LR  - 20190318
IS  - 1433-7339 (Electronic)
IS  - 0941-4355 (Linking)
VI  - 26
IP  - 11
DP  - 2018 Nov
TI  - Feasibility and accessibility of electronic patient-reported outcome measures 
      using a smartphone during routine chemotherapy: a pilot study.
PG  - 3721-3728
LID - 10.1007/s00520-018-4232-z [doi]
AB  - PURPOSE: There is growing interest in integrating electronic patient-reported 
      outcome (PRO) measures into routine oncology practice for symptom monitoring. 
      Here, we evaluated the feasibility and accessibility of electronic PRO measures 
      using a smartphone (PRO-SMART) for cancer patients receiving routine 
      chemotherapy. METHODS: The proposed PRO-SMART application obtains daily personal 
      health record (PHR) data from cancer patients via a smartphone. An analysis 
      report of cumulative PHR data is provided to the clinician in a format suitable 
      for upload to electronic medical records (EMRs). Cancer outpatients who had 
      received at least two cycles of chemotherapy and who were scheduled for two more 
      cycles were enrolled. RESULTS: Between February 2015 and December 2016, 111 
      patients were screened and 101 of these were included. One-hundred patients used 
      PRO-SMART at least once and were included in the final analysis (90.1% overall 
      accessibility among all screened patients). The number of symptomatic adverse 
      events (AEs) related to chemotherapy recorded in EMRs (mean +/- standard deviation 
      [SD]) increased from 0.92 +/- 0.80 to 2.26 +/- 1.80 (P < 0.001), and grading of AEs 
      increased from 0.81 +/- 0.69 to 1.00 +/- 0.62 (P = 0.029). After using PRO-SMART, the 
      numeric rating scale for pain (mean +/- SD) increased from 0.20 +/- 0.72 to 
      0.99 +/- 1.55 (P < 0.001). A patient-reported questionnaire revealed that 64.2% of 
      patients found it useful and 83% found it easy to use. CONCLUSIONS: This study 
      suggests that the proposed PRO-SMART is feasible and accessible for assessment of 
      symptomatic AEs in cancer patients receiving chemotherapy for a prospective 
      randomized trial.
FAU - Bae, Woo Kyun
AU  - Bae WK
AD  - Department of Internal Medicine, Chonnam National University Hwasun Hospital, 
      Hwasun-Gun, South Korea.
FAU - Kwon, Jihyun
AU  - Kwon J
AD  - Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, 
      South Korea.
FAU - Lee, Hyun Woo
AU  - Lee HW
AD  - Department of Internal Medicine, Ajou University School of Medicine, Suwon, South 
      Korea.
FAU - Lee, Sang-Cheol
AU  - Lee SC
AD  - Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, 
      Cheonan, South Korea.
FAU - Song, Eun-Kee
AU  - Song EK
AD  - Department of Internal Medicine, Chonbuk National University Medical School, 
      Jeonju, South Korea.
FAU - Shim, Hyeok
AU  - Shim H
AD  - Department of Internal Medicine, School of Medicine, Wonkwang University, Iksan, 
      South Korea.
FAU - Ryu, Keun Ho
AU  - Ryu KH
AD  - Database/Bioinformatics Laboratory, College of Electrical & Computer Engineering, 
      Chungbuk National University, Cheongju, South Korea.
FAU - Song, Jemin
AU  - Song J
AD  - Turbosoft Inc., Cheongwon, South Korea.
FAU - Seo, Sungbo
AU  - Seo S
AD  - Turbosoft Inc., Cheongwon, South Korea.
FAU - Yang, Yaewon
AU  - Yang Y
AD  - Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, 
      South Korea.
FAU - Park, Jong-Hyock
AU  - Park JH
AD  - College of Medicine/Graduate School of Health Science Business Convergence, 
      Chungbuk National University, Cheongju, South Korea.
FAU - Lee, Ki Hyeong
AU  - Lee KH
AD  - Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, 
      South Korea.
AD  - Department of Internal Medicine, College of Medicine, Chungbuk National 
      University, Chungdae-ro 1, Seowon-gu, Cheongju, 28644, South Korea.
FAU - Han, Hye Sook
AU  - Han HS
AUID- ORCID: 0000-0001-6729-8700
AD  - Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, 
      South Korea. sook3529@hanmail.net.
AD  - Department of Internal Medicine, College of Medicine, Chungbuk National 
      University, Chungdae-ro 1, Seowon-gu, Cheongju, 28644, South Korea. 
      sook3529@hanmail.net.
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
PT  - Multicenter Study
DEP - 20180507
PL  - Germany
TA  - Support Care Cancer
JT  - Supportive care in cancer : official journal of the Multinational Association of 
      Supportive Care in Cancer
JID - 9302957
RN  - 0 (Antineoplastic Agents)
SB  - IM
MH  - *Access to Information
MH  - Adult
MH  - Aged
MH  - Antineoplastic Agents/*therapeutic use
MH  - *Electronic Health Records/statistics & numerical data
MH  - Feasibility Studies
MH  - Female
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Mobile Applications
MH  - Monitoring, Physiologic/*methods/standards
MH  - Neoplasms/*drug therapy
MH  - Pain
MH  - *Patient Reported Outcome Measures
MH  - Pilot Projects
MH  - *Smartphone/statistics & numerical data
MH  - Surveys and Questionnaires
OTO - NOTNLM
OT  - Cancer
OT  - Chemotherapy
OT  - Patient-reported outcome measures
OT  - Smartphone
OT  - Symptom
EDAT- 2018/05/08 06:00
MHDA- 2018/11/06 06:00
CRDT- 2018/05/08 06:00
PHST- 2017/11/03 00:00 [received]
PHST- 2018/04/26 00:00 [accepted]
PHST- 2018/05/08 06:00 [pubmed]
PHST- 2018/11/06 06:00 [medline]
PHST- 2018/05/08 06:00 [entrez]
AID - 10.1007/s00520-018-4232-z [pii]
AID - 10.1007/s00520-018-4232-z [doi]
PST - ppublish
SO  - Support Care Cancer. 2018 Nov;26(11):3721-3728. doi: 10.1007/s00520-018-4232-z. 
      Epub 2018 May 7.